Sector News

Danish consortium acquires part of Jernbanebyen to create one of the world’s healthiest urban villages

October 17, 2021
Life sciences

Jernbanebyen is the last major tranche in the urban renewal of southern and central Copenhagen. This 365,000-m2 development area will be transformed into a new urban district that will have two large parks and three football pitches. With its consistently green character, everyone with a connection to Jernbanebyen will live and work with nature up close in an otherwise partly car-free environment.

One owner, Freja Ejendomme, has just sold its part of Jernbanebyen – a plot of 78,000 m2 – to NREP, Novo Holdings and Industriens Pension, which will thus be involved in developing the area in the future.

“We have long had a dream that Jernbanebyen will become a very special district that sets new standards for preserving and transforming the architectural heritage of the area, for sustainable solutions at both the building and urban village level, and for establishing green, active communities. Having the Baneby Consortium as our new development partner ensures that this will not merely remain a dream but that we can further develop and realise the dream together – we share the same vision,” says Carsten Rasmussen, director at Freja Ejendomme.

Big ambitions
The newly established Baneby Consortium, owned equally by NREP, Novo Holdings and Industriens Pension, will now continue to work with Team Cobe’s project for transforming Jernbanebyen into a green, sustainable urban village, which won the architectural competition for this area in the spring.

“We see great prospects in developing Jernbanebyen, and the investment fits well with Novo Holdings’ strategic focus of investing in sustainable properties and infrastructure. We expect the investment to generate an attractive return and view this as an exciting opportunity to be part of long-term value creation in the Baneby Consortium and thereby contribute to the ambitious, healthy and green development of Copenhagen with its focus on diversity,” says Morten Beck Jørgensen, Managing Partner, Novo Holdings.

Jens Kramer Mikkelsen, Director of Urban Development, NREP, says: “Team Cobe created a fantastic project, and we fully support the City of Copenhagen’s ambition to create an eco-friendly urban village with mixed housing. We will also use this unique opportunity to develop a new district and, together with Freja Ejendomme, Team Cobe and others, create a world-class sustainable urban village. This applies to the environment and climate and especially also health, and with our competencies within buildings and urban spaces, we have set ourselves the goal of creating one of the world’s healthiest urban villages,”

Optimised indoor climate and many recreational areas
The health ambitions will be achieved by such initiatives as reducing the development’s carbon footprint and using environmentally sound and energy-efficient building materials. The buildings will be optimised based on parameters such as indoor climate, acoustics and daylight, and the green spaces and recreational areas between the buildings will characterise life in the southern part of Jernbanebyen and contribute to the area’s biodiversity. Wastewater and food waste will be utilised locally, and there is an ambitious plan for sustainability certification at both the building and urban village levels. For example, the plan is for all residential properties to be certified as DGNB Gold and DGNB Heart.

From vision to local plan
Freja Ejendomme, together with the other landowner, DSB Ejendomsudvikling, has been working for some time to translate Team Cobe’s project submission into a final comprehensive plan that will form the basis for the initial planning report and local plan for Jernbanebyen. Team Cobe, the City of Copenhagen, local committees, neighbours and other stakeholders continue to collaborate on the project in an open and inclusive process. NREP, Novo Holdings and Industriens Pension will now also be included in this work, in which ideas and requirements will be transformed into specific local plans.

“We are pleased to contribute to the development of a new large sustainable urban village for Copenhagen residents. It will be a diverse district, with a really good mix of social housing, housing for young and old people and owner-occupied housing, and we expect many new jobs. This is a long-term investment and a partnership that we expect will provide solid and stable returns for the members for many years to come,” says Jan Østergaard, Head of Unlisted Investments in Industriens Pension.

Freja Ejendomme and the Baneby Consortium will soon start talks with interested actors in Jernbanebyen – including social housing associations in particular.

Development will begin in the southern part of Jernbanebyen, and the agreement between the Baneby Consortium and Freja Ejendomme covers this element. A proposal for a local plan is expected in 2022 with final approval in 2023. Work is expected to begin in 2023 or 2024. Freja Ejendomme will continue to be a key part of the development project until a local plan for the 78,000-m2 site has been adopted.

The sale is subject to the European Commission approving the creation of the Baneby Consortium and an approved local plan.

By Novo Holdings, Press Release

Source: novoholdings.dk

comments closed

Related News

November 28, 2021

Founder-led biotech is making space for ideas—and diverse leaders—where it didn’t exist before

Life sciences

Decades ago, the founder-led biotech was rare and considered the tougher path to follow. Now there is a trend of founder-led biotechs that have risen in prominence in recent years, going from startup to well known with lightning speed. Scientists-turned C-suite occupants know their technology inside out. They’ve got credibility both at the bench working with their research teams and in the boardrooms selling their future products.

November 28, 2021

Pfizer to become $100B behemoth next year thanks to COVID-19 drug and vaccine: analyst

Life sciences

Pfizer’s revenue could reach $101.3 billion in 2022, with major contributions coming from the company’s BioNTech-partnered COVID vaccine and an antiviral therapeutic that has shown stellar clinical data, SVB Leerink analyst Geoffrey Porges projected in a Monday note to clients.

November 28, 2021

GlaxoSmithKline takes aim at sick pay access inequities with microgrant program and new campaign

Life sciences

In a survey commissioned by GlaxoSmithKline’s consumer health division of 2,000 working people in the U.S., almost 70% admitted to clocking in while sick, often because they couldn’t afford to lose a day’s pay. Black and Latina women were 10% more likely than white women to shun taking sick time for fear of fallout from their boss, according to the company’s 2021 Temperature Check Report.

Send this to a friend